Ovid Therapeutics Inc. Stock Issued During Period, Value, Conversion of Convertible Securities
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Ovid Therapeutics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-06-30 was $130.66K.
- Ovid Therapeutics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2021-03-31 was $0.00.
- Ovid Therapeutics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-12-31 was $0.00.
- Ovid Therapeutics Inc. stock issued during period, value, conversion of convertible securities for the quarter ending 2017-09-30 was $0.00.
- Ovid Therapeutics Inc. stock issued during period, value, conversion of convertible securities for fiscal 2021 was $0.00.
- Ovid Therapeutics Inc. stock issued during period, value, conversion of convertible securities for fiscal 2017 was -$464.00.
| Period end | Stock Issued During Period, Value, Conversion of Convertible Securities 3 month | Stock Issued During Period, Value, Conversion of Convertible Securities 12 month |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2023-03-13 | |
| 2021-06-30 | $130.66K 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-11-08 | |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$464.00 10-K · filed 2019-03-07 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |